The Thai Red Cross Society plans to set up a factory in Samut Prakan to produce plasma to reduce the amount spent on importing blood products and to extend access to related treatments.
If it goes ahead, the plant will be the first of its kind in Southeast Asia. Construction is set to begin by the end of this year and is expected to be completed by 2015, said Dr Pinit Kullavanijaya, chairman of the working panel on the planned construction of the factory.
Dr Pinit unveiled the plan after the agency yesterday signed a Memorandum of Understanding with South Korea-based Green Cross Corporation to receive a technological transfer for the production of three plasma products, namely Albumin, Intravenous Immunoglobulin and Factor VIII.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.